CBER Review “Paradigm Shift” Credited With Improved Cycle/Review Stats

The Center for Biologics Evaluation & Research is working to identify problems with premarket applications earlier so they can be resolved in the first cycle of review, according to Robert Yetter, CBER associate director for review management